FDA approved treatment with adult stem cells to be conducted in the United States in January is available to the general public.
Dallas, TX -- (SBWIRE) -- 01/17/2014 -- The Repair Stem Cell Institute (RSCI) – www.repairstemcells.org -- is pleased to announce that it will assist interested patients to take part in a clinical trial based in the United States for the treatment of COPD (Chronic Obstructive Pulmonary Disease). The FDA approved and compliant trial, which uses adult stem cells, will be conducted only during January 2014 in the U.S. states of Florida and Georgia.
The trial is being conducted by the U.S. based company Numed/BioHeart, which has assembled a team of doctors and specialists specially trained in stem cell treatments. Based on previous treatment of COPD with stem cells, it is estimated that two-thirds of participants will experience significant quality of life improvement and symptoms reduction.
In a recent interview, RSCI founder and Chairman Don Margolis stated “With stem cell treatment rapidly coming to the forefront of 21st Century medicine, we are pleased that COPD is among over 150 chronic conditions that are treatable with adult stem cells rather than potentially risky surgery, dangerous transplants, and toxic drugs.”
Patients suffering from COPD who are cancer-free can apply to participate.
What will happen?
The 4-part procedure will be done in a participating doctor’s office as a point-of-care out-patient.
1. Adipose Harvest: During a 3-5 hour visit to the doctor’s office, a mini-liposuction on One's stomach will extract a small amount of tummy fat containing tens of millions of adipose stem cells.
2. Laboratory Processing: The extracted stem cells will be isolated, analyzed, and concentrated.
3. Stem Cell Implantation: Up to 60-70 million stem cells will be transplanted intravenously, usually in their arm. Because these are the patient’s own cells, the risk of rejection can be excluded.
4. Postoperative Care: Normally, patients can leave right after implantation. It is expected that participants will be available for follow-up evaluations for one year.
The cost to each participant in the January trial, including all treatments and follow-up care, is U.S. $5,000. The same procedure can be done any time at approved stem cell treatment centers worldwide, but it will cost between $12,000 – 15,000.
How to participate
Those interested in participating in this trial should contact the Repair Stem Cell Institute as soon as possible since participation is limited to 100 COPD patients.
Stem cells are unique, unspecialized cells in the body with the ability to differentiate into specialized cells for specific organs or develop into tissues. To date, commercial stem cell treatments have been used by over 30,000 patients with a success rate over 65% for more than 150 debilitating chronic conditions.
A patient who has already benefited from COPD treatment with this same procedure wrote to say, “I can’t believe how I am feeling. When I first went for stem cell treatment, on a scale of 1 to 10, my breathing was a 4. Today, two weeks later, I’m a solid 7.”
A full list of diseases stem cells can help can be found on the website of the Repair Stem Cell Institute, often called “The Voice of Stem Cell Science.” RSCI is the world’s only stem cell patients’ advocacy group and is committed to assisting people to make educated choices about their medical conditions and treatments.
For more information about adult stem cells, stem cell treatment, diseases stem cells can help, and the top international stem cell treatment centers, the Repair Stem Cell Institute website offers a wealth of straightforward and unbiased information.
Repair Stem Cell Institute
3010 LBJ Freeway, Suite 1200
Dallas, TX 75234
Tel: 1- (768) 600-1408